Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Clinical trial NCT00360672 · COMPLETED
Trial details
- NCT number
- NCT00360672
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.